Common issues identified during clinical trial applications
The guidance identifies common issues with validation and assessment of clinical trial applications and how to avoid them.
Read the press release story from Medicines and Healthcare products Regulatory Agency published on 6 November 2023.
OpenEdition vous propose de citer ce billet de la manière suivante :
lsgilbert (12 février 2024). Common issues identified during clinical trial applications. ELSIBI. Consulté le 18 février 2025 à l’adresse https://doi.org/10.58079/vto4